{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/01/3304208/0/en/Invivyd-Announces-Completion-of-Enrollment-in-Upsized-DECLARATION-Clinical-Trial-a-Phase-3-Pivotal-Study-of-VYD2311-an-Investigational-Antibody-to-Prevent-COVID.html", "message": "News view counter 769568 successfully enlarged"}